[go: up one dir, main page]

IE72479B1 - Codeine salt of a substituted carbonacid process of its preparation its use and pharmaceutical preparations - Google Patents

Codeine salt of a substituted carbonacid process of its preparation its use and pharmaceutical preparations

Info

Publication number
IE72479B1
IE72479B1 IE297391A IE297391A IE72479B1 IE 72479 B1 IE72479 B1 IE 72479B1 IE 297391 A IE297391 A IE 297391A IE 297391 A IE297391 A IE 297391A IE 72479 B1 IE72479 B1 IE 72479B1
Authority
IE
Ireland
Prior art keywords
salt
codeine
formula
acetic acid
dichlorophenyl
Prior art date
Application number
IE297391A
Other languages
English (en)
Other versions
IE912973A1 (en
Inventor
Walter Riess
Alfred Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE912973A1 publication Critical patent/IE912973A1/en
Publication of IE72479B1 publication Critical patent/IE72479B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE297391A 1990-08-23 1991-08-22 Codeine salt of a substituted carbonacid process of its preparation its use and pharmaceutical preparations IE72479B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH273590 1990-08-23

Publications (2)

Publication Number Publication Date
IE912973A1 IE912973A1 (en) 1992-02-26
IE72479B1 true IE72479B1 (en) 1997-04-23

Family

ID=4240432

Family Applications (1)

Application Number Title Priority Date Filing Date
IE297391A IE72479B1 (en) 1990-08-23 1991-08-22 Codeine salt of a substituted carbonacid process of its preparation its use and pharmaceutical preparations

Country Status (20)

Country Link
US (1) US5190947A (xx)
EP (1) EP0472501B1 (xx)
JP (1) JPH04257587A (xx)
KR (1) KR920004391A (xx)
AT (1) ATE137753T1 (xx)
AU (1) AU652951B2 (xx)
CA (1) CA2049649A1 (xx)
DE (1) DE59107784D1 (xx)
DK (1) DK0472501T3 (xx)
ES (1) ES2086515T3 (xx)
FI (1) FI96421C (xx)
GR (1) GR3019872T3 (xx)
HU (1) HU209308B (xx)
IE (1) IE72479B1 (xx)
IL (1) IL99213A (xx)
NO (1) NO179175C (xx)
NZ (1) NZ239495A (xx)
PT (1) PT98731B (xx)
TW (1) TW225536B (xx)
ZA (1) ZA916642B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072462T3 (es) * 1991-02-07 1995-07-16 Heumann Pharma Gmbh & Co Nuevas sales del acido 2-(2,6-dicloroanilino)fenilacetico, procedimiento para su elaboracion y uso de las mismas en preparados farmaceuticos de uso topico.
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
HUP0003686A3 (en) * 1997-09-25 2003-04-28 Lohmann Therapie Syst Lts Acidic addition salts of morphine alkaloids and the application thereof
AR034362A1 (es) * 2001-06-05 2004-02-18 Control Delivery Systems Compuestos analgesicos de liberacion prolongada
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
DK1765292T3 (en) 2004-06-12 2018-01-02 Collegium Pharmaceutical Inc ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS
US20090291121A1 (en) * 2008-05-23 2009-11-26 Symrise, Inc. Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
PT2405748T (pt) 2009-03-12 2018-11-23 Cumberland Pharmaceuticals Inc Administração de ibuprofeno intravenoso
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2013112456A1 (en) 2012-01-24 2013-08-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Controlled release formulations for the induction and proliferation of blood cells
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA537946A (en) * 1957-03-12 J. Lewenstein Mozes Process for preparing improved compounds having narcotic effect
US936254A (en) * 1908-01-06 1909-10-05 Belden Mfg Co Attachment for telephones.
DE377588C (de) * 1922-08-29 1923-06-22 O Hinsberg Dr Verfahren zur Darstellung einer salzartigen Verbindung des Codeins
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US3895063A (en) * 1965-04-08 1975-07-15 Ciba Geigy Corp Substituted Anilino Benzyl Alcohols
FR2051482B1 (xx) * 1969-04-04 1973-06-08 Rabot Ets David
CA964192A (en) * 1970-07-21 1975-03-11 Roy H. Reiner Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone
FR2257606B1 (xx) * 1974-01-10 1978-02-24 Sumitomo Chemical Co
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.

Also Published As

Publication number Publication date
HUT60501A (en) 1992-09-28
US5190947A (en) 1993-03-02
IL99213A0 (en) 1992-07-15
KR920004391A (ko) 1992-03-27
FI96421B (fi) 1996-03-15
FI913949A0 (fi) 1991-08-21
EP0472501A2 (de) 1992-02-26
ZA916642B (en) 1992-04-29
ATE137753T1 (de) 1996-05-15
ES2086515T3 (es) 1996-07-01
CA2049649A1 (en) 1992-02-24
NO179175B (no) 1996-05-13
TW225536B (xx) 1994-06-21
PT98731A (pt) 1992-07-31
HU209308B (en) 1994-04-28
AU8268591A (en) 1992-02-27
IE912973A1 (en) 1992-02-26
PT98731B (pt) 1999-01-29
DE59107784D1 (de) 1996-06-13
IL99213A (en) 1995-07-31
FI913949L (fi) 1992-02-24
NZ239495A (en) 1997-05-26
DK0472501T3 (da) 1996-05-28
EP0472501B1 (de) 1996-05-08
HU912768D0 (en) 1992-01-28
FI96421C (fi) 1996-06-25
NO913295L (no) 1992-02-24
EP0472501A3 (en) 1993-02-24
GR3019872T3 (en) 1996-08-31
NO179175C (no) 1996-08-21
AU652951B2 (en) 1994-09-15
NO913295D0 (no) 1991-08-22
JPH04257587A (ja) 1992-09-11

Similar Documents

Publication Publication Date Title
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
EP0415850B1 (fr) Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant
IL30394A (en) Phenylacetic acid derivatives
GB2038818A (en) ???,???-Dihydropolyprenyl Alcohols and Pharmaceutical Compositions thereof
SK216092A3 (en) Using of xantine derivatives for treating of secondary lesions of neurous cells and functional defects after injuring of cranium and cerebrum
JPS6072843A (ja) ４−フエニル−４−オキソ−２−ブテン酸の新誘導体、それらの製造法、薬剤としての使用及びそれらを含む組成物
US3953601A (en) Dibenzothiophene derivatives as serum lipid lowering agents
EP0133423B1 (en) Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine
US3870792A (en) Certain dihydrophthalizines for treating hemorrhage and thrombosis
DE69515498T2 (de) Naphthyridinderivate
NZ196683A (en) Salts of 6-methylamino-4-oxo-10-propyl-4h-pyrano (3,2,-g) quinoline-2,8-dicarboxylic acid
GB2162175A (en) 1,8-diacyloxy-10-acylanthrones
JPS6320426B2 (xx)
US3966960A (en) 3-(4-Biphenylcarbonyl)propionic acid as an inhibitor of platelet aggregation
JPH06279432A (ja) 新規な化合物および該化合物を有効成分とする抗癌剤
US4181737A (en) 4-((3-Methoxyphenyl)amino)benzoic acid, a method for treating hyperlipidemia, and compositions thereof
CA1072969A (en) Hypolipidemic p-aminobenzoic acids
JPS60188373A (ja) 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
CA1301776C (en) Compound of choline, a process for its preparation and therapeutic composition containing it
US4215143A (en) Anti-ulcer pharmaceutical composition containing inositol hexasulfate aluminum or sodium aluminum salt as active ingredient
JP3242975B2 (ja) 消化管運動機能改善剤
JPS6123796B2 (xx)
CH648295A5 (fr) Acides 2-amino-3-(alkylthiobenzyl)-phenylacetiques et leurs derives.
IE46713B1 (en) 4-(2-thienylmethylamino)benzoic acid compounds
GB1603651A (en) Normolipidemiant compositions

Legal Events

Date Code Title Description
MM4A Patent lapsed